v3.26.3
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenue $ 1,845 $ 1,792 $ 5,518 $ 5,779
Cost of revenue (864) (796) (2,626) (2,488)
Gross Profit 981 996 2,892 3,291
Operating expenses:        
Selling and marketing 356 293 1,151 934
General and administrative 2,653 1,632 8,904 5,131
Research and development 286 165 876 489
Total operating expenses 3,295 2,090 10,931 6,554
Loss from operations (2,314) (1,094) (8,039) (3,263)
Other (expense) income:        
Interest expense (353) (74) (459) (213)
Loss on extinguishment of convertible notes payable (391)
Gain on extinguishment of payable 105 612
Gain/(loss) on change in fair value of convertible notes and warrant liability 42 (61) 91 (1,405)
Loss on change in fair value of forward purchase derivative liability (2,212) (604)
Other (expense) income 109 55 59 59
Total other (expense)/income, net (2,309) (80) (301) (1,950)
Loss before income taxes (4,623) (1,174) (8,340) (5,213)
Provision for income tax (4)
Net loss (4,623) (1,174) (8,344) (5,213)
Deemed dividend related to Shortfall Warrants modification     (84)
Net loss attributable to common stockholders (i) $ (4,623) $ (1,174) $ (8,428) $ (5,213)
Weighted-average common shares outstanding - basic 30,586,609 7,672,654 29,502,942 7,406,332
Weighted-average common shares outstanding - diluted 30,586,609 7,672,654 29,502,942 7,406,332
Net loss per common share - basic $ (0.15) $ (0.15) $ (0.29) $ (0.70)
Net loss per common share - diluted $ (0.15) $ (0.15) $ (0.29) $ (0.70)
Other Comprehensive income (loss)        
Change in foreign currency translation adjustment $ 2 $ 8 $ 11 $ 8
Total comprehensive loss $ (4,621) $ (1,166) $ (8,333) $ (5,205)